TSE:471A stock news
This page provides real-time market news, earnings updates, and company announcements related to NS Group,Inc. (TSE:471A).
All content is aggregated from trusted financial media and market data sources to help investors stay informed about key market movements and corporate developments.
Last updated as of 2026-04-18 03:28 JST
TRX News Today: Institutional Demand Drives $3.88 Trillion Crypto Boom: MoonBull, Chainlink, and Tron at the Forefront of Expansion
Bitget-RWA2025-10-28 06:12:10
Strategic token distributions and repurchase initiatives fuel sustained expansion in the crypto sector
Bitget-RWA2025-11-03 14:08:05
Capricor Therapeutics Announces Late-Breaking Presentation at 2026 MDA Clinical and Scientific Conference
Finviz2026-02-24 14:03:51
Mineralys Therapeutics Announces FDA Acceptance of NDA for Lorundrostat for Treatment of Adults with Hypertension and Topline Explore-OSA Trial Results
Finviz2026-03-09 20:40:44
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
Finviz2026-03-10 13:28:16
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:06:49
Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:51
US Stock Movement | Faraday Future rises 3.5% pre-market as EAI robot business continues to deliver positive gross margin
格隆汇2026-03-13 08:24:34
Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome
Finviz2026-03-25 12:33:52
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-03-26 12:33:42
Oxbridge Highlights Strong 2025-26 Performance, Platform Expansion, and Market Opportunity; Reports Q4 and Full-Year Results
Finviz2026-03-30 20:33:43
Rigetti Announces General Availability of 108-Qubit System
Finviz2026-04-07 20:09:35
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Finviz2026-04-13 11:33:06
Microchip Expands dsPIC33A DSC Family for High-Density AI Data Center Power, Complex Motor Control and Intelligent Sensing
Finviz2026-04-14 10:18:49
Capricor Therapeutics Announces Establishment of New PDUFA Date for Deramiocel BLA
Finviz2026-03-10 13:28:16
Capricor Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:06:49
Mineralys Therapeutics Reports Fourth Quarter 2025 Financial Results and Provides Corporate Update
Finviz2026-03-12 20:09:51
US Stock Movement | Faraday Future rises 3.5% pre-market as EAI robot business continues to deliver positive gross margin
格隆汇2026-03-13 08:24:34
Quoin Pharmaceuticals Provides Clinical and Regulatory Update from Constructive Type C Meeting with U.S. FDA for QRX003 in Netherton Syndrome
Finviz2026-03-25 12:33:52
Quoin Pharmaceuticals Provides Corporate Update and Reports Fourth Quarter and Full-Year 2025 Financial Results
Finviz2026-03-26 12:33:42
Oxbridge Highlights Strong 2025-26 Performance, Platform Expansion, and Market Opportunity; Reports Q4 and Full-Year Results
Finviz2026-03-30 20:33:43
Rigetti Announces General Availability of 108-Qubit System
Finviz2026-04-07 20:09:35
Allogene Therapeutics Reports Interim Futility Analysis from Pivotal ALPHA3 Trial Showing 58.3% MRD Clearance with Cemacabtagene Ansegedleucel (Cema-Cel) vs. 16.7% in Observation Arm in First-Line Consolidation LBCL
Finviz2026-04-13 11:33:06
Microchip Expands dsPIC33A DSC Family for High-Density AI Data Center Power, Complex Motor Control and Intelligent Sensing
Finviz2026-04-14 10:18:49
TSE:471A stock price change
On the last trading day, TSE:471A stock closed at 1731.00 JPY, with a price change of 0.64% for the day.
Trade stock perpsTSE:471A stock detailsAbout Bitget
The world's first Universal Exchange (UEX), enabling users to trade not only cryptocurrencies, but also stocks, ETFs, forex, gold, and real-world assets (RWA).
Learn more